John P. Saharek - CEO & President, ImprimisRx at HARROW, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO & President, ImprimisRx
Issuer Symbol
HROW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John P. Saharek since 30 Jan 2025

Holdings reported by John P. Saharek for HARROW, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 467,388 $10,791,989 $23.09 07 Apr 2025 Direct
Performance Stock Unit 0 $0 $23.09 03 Apr 2025 Direct Common Stock
Stock Option (Right to Buy) 0 11 Sep 2024 Direct Common Stock

Transactions reported by John P. Saharek for HARROW, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.